Evaluation of a Novel MAGEC1 Variant and Susceptibility to Ovarian Cancer in the North Indian Population
Genetic Testing and Molecular Biomarkers · 2025
DOI: 10.1089/gtmb.2025.0029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetic Testing and Molecular Biomarkers, 2025. Verfasst von Minerva Sharma und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology, Shri Mata Vaishno Devi University, Katra, India. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Antigens, Neoplasm, Neoplasm Proteins. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Objective
To check the correlation between the MAGE Family Member C1 (MAGEC1) gene variant rs176036 and ovarian cancer risk among the Jammu and Kashmir population. Methodology: A case-control association study of the MAGEC1 gene variant rs176036 (G > A) and ovarian cancer. The variation was identified through whole exome sequencing, and the selected variant was genotyped in 111 patients with ovarian cancer and 107 healthy controls belonging to the Jammu and Kashmir region of North India using Sanger sequencing to confirm its association with the ovarian cancer. Odds ratio (OR) and other statistical values were calculated using standard tools.
Results
The allelic frequency distribution was found to be similar between cases and controls, with the dominant allele (G) present in 89.6% of cases and 90.2% of controls (p = 0.84). The allelic OR for the dominant allele was 1.08 (0.55-2.11), which is nonsignificant (p = 0.83).
Conclusion
The present study suggests that the rs176036 variant does not confer any increased risk of ovarian cancer among population of Jammu and Kashmir.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biotechnology, Shri Mata Vaishno Devi University, Katra, India.
- Indian Council of Medical Research-Centre for Advance Research, Shri Mata Vaishno Devi University, Katra, India.
- Centre for Molecular Biology, Central University of Jammu, Jammu & Kashmir, India.
- Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, India.
- Department of Medicine, ASCOMS, Jammu, India.
ORCID-Profile: Rakesh Kumar
Zitieren
APA
Sharma, M., Verma, S., Bhagat, V., Tufail, Z., Jamwal, R. S., Sharma, B., Chander, G., Shah, R., Bhat, A., Dhar, M., Singh, S., & Kumar, R. (2025). Evaluation of a Novel MAGEC1 Variant and Susceptibility to Ovarian Cancer in the North Indian Population. Genetic Testing and Molecular Biomarkers. https://doi.org/10.1089/gtmb.2025.0029
Vancouver
Sharma M, Verma S, Bhagat V, Tufail Z, Jamwal RS, Sharma B, et al. Evaluation of a Novel MAGEC1 Variant and Susceptibility to Ovarian Cancer in the North Indian Population. Genetic Testing and Molecular Biomarkers. 2025. doi:10.1089/gtmb.2025.0029
BibTeX
@article{Sharma2025,
author = {Sharma, Minerva and Verma, Sonali and Bhagat, Vanshika and Tufail, Ziya and Jamwal, Rajeshwer Singh and Sharma, Bhawani and Chander, Gresh and Shah, Ruchi and Bhat, Audesh and Dhar, Manushi and Singh, Supinder and Kumar, Rakesh},
title = {Evaluation of a Novel MAGEC1 Variant and Susceptibility to Ovarian Cancer in the North Indian Population},
journal = {Genetic Testing and Molecular Biomarkers},
year = {2025},
doi = {10.1089/gtmb.2025.0029}
}
EUVIMED